When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BMY - European advisory group backs Bristol-Myers and Acceleron's luspatercept
Bristol-Myers Squibb Company
The European Medicines Agency's advisory group CHMP has adopted a positive opinion backing approval of Bristol-Myers Squibb (NYSE:BMY) and development partner Acceleron Pharma's (NASDAQ:XLRN) Reblozyl (luspatercept) for the treatment of:
More news on: Bristol-Myers Squibb Company, Acceleron Pharma Inc., Healthcare stocks news,